Intranasal Oxytocin for the Treatment of Alcohol Use Disorder
NCT03878316
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
NIH
Sponsor class
Conditions
Alcohol Use Disorder
Alcohol Misuse
Interventions
DRUG:
Instranasal Oxytocin
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)